You are here

Home » News and Media

News and Media

- Any -
CRISPR-Cas9. Image by Ian Slaymaker, Broad Institute
Press releases / 07.10.17
Broad Institute of MIT and Harvard joins discussions to create worldwide CRISPR-Cas9 licensing pool
If other key patent holders join, pool would expand access and streamline non-exclusive licensing for commercial useRead more
Susanna M. Hamilton, Broad Communications
Blog / 07.6.17
The science behind the story: Following a cancer vaccine from concept to proof of concept
The successful early-stage clinical trial of a personalized cancer vaccine for melanoma represents the culmination of almost a decade’s collaborative work to overcome challenges large and small.Read more
Susanna M. Hamilton, Broad Communications
News / 07.5.17
Cracks in the armor of therapy-resistant cancer cells
A new study shows that cancer cells across multiple lineages can adopt the same therapy-resistant cell state, enabling broad resistance to targeted therapies. However, the resulting cell circuitry also results in a vulnerability that can be exploited to induce a form of cell death called ferroptosis.Read more
Image courtesy of Susanna Hamilton, Broad Communications, from material provided by Leslie Gaffney and Lauren Solomon.
News / 06.29.17
Turning risk-association to biological insight in T2D
Following up on findings from genome-wide association studies, researchers identify two mechanisms by which disruptions in the gene SLC16A11 may play a role in type 2 diabetesRead more
Susanna M. Hamilton, Broad Communications
News / 06.28.17
The breast cancer genome’s “dark matter” starts to give up some secrets
While mutations in protein-coding genes have held the limelight in cancer genomics, those in the noncoding genome (home to the regulatory elements that control gene activity) may also have powerful roles in driving tumor growth. A new study reveals recurrent mutations in nine such noncoding elements in breast cancer.Read more